HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPA Stirs ‘Natural’ Debate With Supplement Certification Planned

This article was originally published in The Tan Sheet

Executive Summary

The Natural Products Association eyes adopting a definition for “natural” foods and dietary supplement products, executive Corey Hilmas says at NAD’s annual conference. An NPA committee is currently determining the approach the trade group will use to adopt a standard and certify products as compliant.

You may also be interested in...



FTC Warns 37 'Green' Seal Certifiers, Users For Potential Deception

In warning letters to five environmental seal certifiers and 32 businesses that use those seals, the Federal Trade Commission says it is concerned that the logos could be deceptive and potentially mislead consumers. Meanwhile, increased FTC attention to "green" claims and certification programs makes more conspicuous the agency's relative inaction regarding similarly marketed "natural" products.

NPA Contests Claim That NSF/NATRUE Natural Standard Will Be U.S. First

The Natural Products Association reacted with indignation to the suggestion that criteria NSF International and NATRUE are developing will constitute "the first American national standard for natural personal-care products."

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel